Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas

Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningfagfællebedømt

OriginalsprogEngelsk
Publikationsdato2011
Antal sider1
StatusUdgivet - 2011
Begivenhed8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease - Lisbon, Portugal
Varighed: 9 mar. 201111 mar. 2011

Konference

Konference8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease
LandPortugal
ByLisbon
Periode09/03/201111/03/2011

ID: 257379666